Lu Zhou
Sheffield, ENG S102TT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: Combined Inhibition of NEDD8-activating Enzyme and mTOR Suppresses NF2 Loss-driven Tumorigenesis.
Journal: Molecular cancer therapeutics
Published: February 06, 2021
Aromatic Residues in the Fourth Transmembrane-Spanning Helix M4 Are Important for GABAρ Receptor Function.
Journal: ACS chemical neuroscience
Published: November 10, 2017
Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis.
Journal: Molecular cancer therapeutics
Published: November 30, 2016
The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours.
Journal: Molecular oncology
Published: May 20, 2014
Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
Journal: Cancer cell
Published: July 01, 2013
The role of insulin-like growth factors signaling in merlin-deficient human schwannomas.
Journal: Glia
Published: April 30, 2012
Merlin, a multi-suppressor from cell membrane to the nucleus.
Journal: FEBS letters
Published: February 15, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026